1. Home
  2. OCSL vs CDNA Comparison

OCSL vs CDNA Comparison

Compare OCSL & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCSL
  • CDNA
  • Stock Information
  • Founded
  • OCSL 2007
  • CDNA 1998
  • Country
  • OCSL United States
  • CDNA United States
  • Employees
  • OCSL N/A
  • CDNA N/A
  • Industry
  • OCSL Finance: Consumer Services
  • CDNA Medical Specialities
  • Sector
  • OCSL Finance
  • CDNA Health Care
  • Exchange
  • OCSL Nasdaq
  • CDNA Nasdaq
  • Market Cap
  • OCSL 1.2B
  • CDNA 1.0B
  • IPO Year
  • OCSL 2008
  • CDNA 2014
  • Fundamental
  • Price
  • OCSL $14.40
  • CDNA $11.98
  • Analyst Decision
  • OCSL Hold
  • CDNA Buy
  • Analyst Count
  • OCSL 7
  • CDNA 6
  • Target Price
  • OCSL $16.00
  • CDNA $29.33
  • AVG Volume (30 Days)
  • OCSL 700.8K
  • CDNA 1.9M
  • Earning Date
  • OCSL 08-05-2025
  • CDNA 07-30-2025
  • Dividend Yield
  • OCSL 11.23%
  • CDNA N/A
  • EPS Growth
  • OCSL N/A
  • CDNA N/A
  • EPS
  • OCSL 0.11
  • CDNA 1.07
  • Revenue
  • OCSL $353,866,000.00
  • CDNA $346,421,000.00
  • Revenue This Year
  • OCSL N/A
  • CDNA $13.31
  • Revenue Next Year
  • OCSL N/A
  • CDNA $15.46
  • P/E Ratio
  • OCSL $131.12
  • CDNA $11.08
  • Revenue Growth
  • OCSL N/A
  • CDNA 25.92
  • 52 Week Low
  • OCSL $12.50
  • CDNA $10.96
  • 52 Week High
  • OCSL $18.46
  • CDNA $34.84
  • Technical
  • Relative Strength Index (RSI)
  • OCSL 63.65
  • CDNA 24.44
  • Support Level
  • OCSL $14.36
  • CDNA $10.96
  • Resistance Level
  • OCSL $14.77
  • CDNA $20.46
  • Average True Range (ATR)
  • OCSL 0.24
  • CDNA 1.35
  • MACD
  • OCSL 0.09
  • CDNA -0.83
  • Stochastic Oscillator
  • OCSL 88.31
  • CDNA 11.11

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: